Thyroid hormone & metamorphic ipsilateral projection
Thyroid hormone & metamorphic ipsilateral projection
批准号:
7341601
负责人:
NICHOLAS R MARSH-ARMSTRONG
金额:
$38.3万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-01 至 2009-11-30
关键词:
AffectAnimal ModelAxonBindingBiological AssayBiological MetamorphosisBrainCell ProliferationCell physiologyCellsClassDataDevelopmentEvolutionEyeFigs - dietaryGene Expression RegulationGenesHormonesIn Situ HybridizationInvestigationIpsilateralKnowledgeLabelLinkMammalsMediatingMethodsMolecularNervous system structureNeuropilin-1Optic ChiasmPatternPhysiologicalPlasmidsPrincipal InvestigatorPropertyProteinsRanaRegulationRegulator GenesRelative (related person)RetinaRetinalRetinal Ganglion CellsStem cellsStudy SectionTestingThalamic structureTherapeutic InterventionThyroid HormonesTimeTranscriptional RegulationTransgenesTransgenic AnimalsTransgenic OrganismsTransplantationVertebratesVisual PathwaysXenopusXenopus laevisaxon guidancecell typecritical developmental periodganglion cellgene functionin vivoinsightnerve stem cellnerve supplynovelprogenitorprogramsrepairedresearch studyresponsetranscription factor
中文摘要
描述(由申请人提供):拟议研究的广泛,长期目标是了解祖细胞内的基因调控如何影响源自这些祖细胞的细胞的命运。了解视网膜祖细胞在这种情况下是如何被激素调节的,将有助于了解这些重要细胞的基本知识,这可能有助于开发旨在通过促进内源性修复反应或通过移植祖细胞修复受损视网膜的治疗干预措施。在这个应用中,重点将是TH如何在视网膜祖细胞中起作用,促进非洲爪蟾的同侧投影。利用这种模式生物的多种实验优势,对祖细胞和神经节细胞命运调控的独特分子见解将出现。该应用程序的具体目的是:1)确定甲状腺激素在控制同侧投影发展中的作用的时间和地点;2)确定甲状腺激素调节基因Xmamdc2是否在视交叉轴突的转动中起作用,以及它的功能是否与另一类轴突引导分子EphBs的已知功能相似或不同;3)确定一个推定转录因子Zic2是否通过调节EphBs或Xmamdc2的表达来调节同侧投影,确定Zic2或其他甲状腺激素调节基因的作用是否通过其在祖细胞或分化神经节细胞中的表达来介导。为了达到这些目的,同侧投影将通过定量逆行和顺行标记方法进行分析。为了在整个神经系统中表达基因产物,或仅在眼睛中表达,或专门表达祖细胞或神经节细胞,将用质粒和BAC转基因制造数百只转基因动物。这些研究将对同侧视网膜丘脑投影的形成方式产生新的见解,将揭示轴突引导的新机制,并将揭示甲状腺激素调节视网膜祖细胞命运的机制。虽然实验将在爪蟾身上进行,但研究结果将适用于包括哺乳动物在内的其他脊椎动物。
英文摘要
DESCRIPTION (provided by applicant): The broad, long-term objective of the proposed studies is to understand how gene regulation within progenitor cells affects the fate of cells that derive from these progenitors. Understanding how retina progenitors are regulated, in this case by a hormone, will contribute essential knowledge about these important cells that may aid in developing therapeutic interventions that aim to repair the damaged retina either by promoting an endogenous repair response, or by transplanting progenitor cells. In this application, the focus will be on how TH functions in retina progenitors to promote the ipsilateral projection in the frog Xenopus laevis. Capitalizing on multiple experimental advantages of this model organism, unique molecular insight into the regulation of progenitor cell and ganglion cell fate will emerge. The specific aims of this application are to: 1) determine the time and place of thyroid hormone action in controlling the development of the ipsilateral projection; 2) determine both whether a thyroid hormone regulated gene, Xmamdc2, which preliminary data show is expressed and functional in ipsilaterally projecting ganglion cells, functions in the turning of axons at the optic chiasm, and whether its function is similar or different from the known function of another class of axon guidance molecules, the EphBs; 3) determine whether a putative-transcription factor, Zic2, regulates the ipsilateral projection by regulating the expression of EphBs or Xmamdc2, and determine whether the action of Zic2 or other thyroid hormone regulated genes is mediated by their expression in either progenitor cells or differentiated ganglion cells. To meet these aims, the ipsilateral projection will be assayed by quantitative retrograde and anterograde labeling methods. Hundreds of transgenic animals will be made with plasmid and BAC transgenes in order to express gene products in the entire nervous system, only in the eye, or specifically to progenitor cells or ganglion cells. These studies will yield novel insight as to how the ipsilateral retinothalamic projection forms, will reveal a novel mechanism involved in axon guidance, and will uncover the mechanism by which thyroid hormone regulates the fate of retina progenitor cells. Though the experiments will be performed in Xenopus, the findings will be applicable to other vertebrates, including mammals.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Xenopus laevis P23H rhodopsin transgene causes rod photoreceptor degeneration that is more severe in the ventral retina and is modulated by light.
非洲爪蟾 P23H 视紫红质转基因导致视杆细胞变性,这种变性在腹侧视网膜中更为严重,并受到光的调节。
DOI:
10.1016/j.exer.2008.01.005
发表时间:
2008
期刊:
Experimental eye research
影响因子:
3.4
作者:
[Zhang,Rui, Oglesby,Ericka, Marsh-Armstrong,Nicholas]
通讯作者:
Marsh-Armstrong,Nicholas
Optic nerve head glymphatics and debris clearance in glaucoma
-
批准号:10200062
-
项目类别:
-
资助金额:$52.86万
-
财政年份:2018
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head glymphatics and debris clearance in glaucoma
-
批准号:10455455
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2018
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells
-
批准号:9899992
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2016
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Axonal mitochondria degradation as the Achilles heel of retinal ganglion cells
-
批准号:9198767
-
项目类别:
-
资助金额:$44.36万
-
财政年份:2016
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
-
批准号:8500298
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
-
批准号:8042280
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Optic nerve head synucleinopathy in glaucoma and the function of gamma-synuclein
-
批准号:8298971
-
项目类别:
-
资助金额:$40.4万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA
-
批准号:8361930
-
项目类别:
-
资助金额:$2.47万
-
财政年份:2011
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
GAMMA SYNUCLEIN AGGREGATES AND GLAUCOMA
-
批准号:8169646
-
项目类别:
-
资助金额:$2.39万
-
财政年份:2010
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Role of a Novel Corepressor in Nuclear Receptor Action
-
批准号:7217882
-
项目类别:
-
资助金额:$28.73万
-
财政年份:2006
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Role of a Novel Corepressor in Nuclear Receptor Action
-
批准号:7369766
-
项目类别:
-
资助金额:$28.24万
-
财政年份:2006
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Role of a Novel Corepressor in Nuclear Receptor Action
-
批准号:7597079
-
项目类别:
-
资助金额:$28.27万
-
财政年份:2006
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Photoreceptor Degeneration Assay-Transgenic Xenopus(RMI)
-
批准号:7021338
-
项目类别:
-
资助金额:$18.3万
-
财政年份:2005
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:7172223
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:6983394
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
Thyroid hormone & metamorphic ipsilateral projection
-
批准号:6852954
-
项目类别:
-
资助金额:$36.23万
-
财政年份:2004
-
负责人:NICHOLAS R MARSH-ARMSTRONG
-
依托单位:
海外基金